loading...| Preferred Name |
dolutegravir |
|
| Synonyms |
dolutegravir sodium monohydrate |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C562325 |
|
| altLabel |
dolutegravir sodium monohydrate dolutegravir sodium GSK 1349572A (4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide GSK1349572A dolutegravir S,R isomer GSK-1349572A (4S,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide (4S,12aR)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide GSK-1349572 S-GSK1349572 Tivicay Tivicay PD dolutegravir S,S-isomer (4R,9aS)-5-hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid- 2,4 difluorobenzylamide |
|
| cui |
C3658160 C3539953 C5772323 C3661280 C3253985 C5398319 C3542464 C5772324 C3253986 |
|
| HM |
D010078 D006575 D010879 D011728 |
|
| Inverse of RB |
DKO1W9H7M1 S3BN9Q9EHW 0E1T06685X FGD6SPP2VH 1Q1V9V5WYQ 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D010879 http://purl.bioontology.org/ontology/MESH/D010078 |
|
| MDA |
20111113 |
|
| MeSH Frequency |
1018 |
|
| MMR |
20220810 |
|
| notation |
C562325 |
|
| PA |
D019428 |
|
| prefLabel |
dolutegravir |
|
| RR |
S3BN9Q9EHW 0E1T06685X FGD6SPP2VH 1Q1V9V5WYQ |
|
| SC |
1 |
|
| Scope Statement |
an HIV-1 integrase inhibitor |
|
| SRC |
Antimicrob Agents Chemother 2010 Jan;54(1):254-8 |
|
| TERMUI |
T001091654 T847895 T800474 T847894 T001123199 T001123195 T847898 T001116669 T847899 T847897 T001123197 T800473 T847896 T001123194 T001123196 T001123198 |
|
| TH |
FDA SRS (2013) FDA SRS (2017) NLM (2022) NLM (2021) USAN (19XX) INN (19XX) NLM (2014) NLM (2011) |
|
| tui |
T109 T129 T121 |